Its capacity to modulate extracellular ATP signaling—possibly by influencing ATP release or degradation—may indirectly affect P2X7 receptor activity and downstream effects within the tumor microenvironment (TME) [44]. The gene discussed is P2RX7; the disease is neoplasm.